CRHR1 rs17689918: Understanding Stress Response Genetics
The rs17689918 variant is a single nucleotide polymorphism located within the CRHR1 gene, which plays a central role in the body's stress response system. Research investigates how this variant may influence individual reactivity to psychosocial stress and susceptibility to anxiety or depression.
What each genotype means
Typical stress response profile
This genotype represents the major allele combination for this variant. Research suggests that individuals with this profile do not carry the specific genetic variation associated with altered CRHR1 expression and increased panic disorder risk observed in some studies. This result should be viewed as a baseline, as stress response is influenced by many other genetic and environmental factors.
This is the most common genotype in European populations, carried by the majority of individuals.
Potential stress sensitivity
Carrying one copy of the minor allele (T) may be associated with subtle differences in how the brain processes stress signals. Some studies have linked this allele to decreased CRHR1 expression in specific brain regions, which may influence fear processing and anxiety-related traits. Because this association is based on limited evidence, it is not a diagnostic indicator and should not be used to predict individual mental health outcomes.
This heterozygous genotype is found in a significant portion of the population, consistent with a minor allele frequency of approximately 0.25–0.35 in European ancestries.
Increased stress reactivity risk
Individuals with this genotype carry two copies of the minor allele, which has been associated in some research with an increased risk for panic disorder, particularly in females. This variant may influence the regulation of the hypothalamic-pituitary-adrenal (HPA) axis and fear processing in the amygdala. These findings are based on statistical associations in specific study cohorts and do not imply a certainty of developing any condition.
This homozygous genotype is the least common of the three, occurring in roughly 6% to 12% of individuals of European ancestry.
What is rs17689918?
The rs17689918 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located within the CRHR1 gene. In genetic databases, this variant is identified by its rsID, which serves as a unique label for researchers tracking specific positions in the human genome. This particular SNP is situated in an intronic region of the gene, meaning it does not directly code for a protein sequence but may influence how the gene is regulated or expressed. Geneticists study such variants to understand how subtle differences in DNA sequence contribute to the biological diversity observed in human populations, particularly regarding how individuals process and respond to environmental stressors.
The Role of the CRHR1 Gene
The CRHR1 gene provides instructions for creating the corticotropin-releasing hormone receptor 1. This receptor is a critical component of the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary system for managing stress. When the body perceives stress, the hypothalamus releases corticotropin-releasing hormone, which binds to CRHR1 receptors in the pituitary gland and other brain regions. This binding triggers a cascade of physiological responses, including the release of cortisol. Because of its key position in regulating this pathway, the CRHR1 gene is a frequent subject of study in psychiatric genetics. Variations in this gene are hypothesized to alter the sensitivity or efficiency of the HPA axis, potentially impacting how an individual experiences and recovers from stressful events.
Research and Evidence Strength
Scientific evidence linking rs17689918 to specific health outcomes is currently considered limited. While the CRHR1 gene as a whole is well-documented for its role in stress-related disorders, individual SNPs like rs17689918 often show mixed or weak associations across different studies. Some research has explored the role of CRHR1 variants in the context of antidepressant treatment response or susceptibility to depression and anxiety, but these findings are not always consistent across diverse populations. It is important to note that complex traits like anxiety and depression are polygenic, meaning they are influenced by hundreds of genetic variants, environmental factors, and life experiences. Consequently, a single SNP like rs17689918 is unlikely to be a definitive predictor of any psychiatric condition.
Population Frequency
The frequency of the rs17689918 variant varies across different ancestral groups. In many European populations, the minor allele frequency is reported to be approximately 0.25 to 0.35. This means that a significant portion of the population carries at least one copy of the variant allele. Because allele frequencies can differ substantially between populations, researchers must be cautious when generalizing findings from one group to another. Understanding these frequency distributions is essential for large-scale genetic studies, as it helps scientists determine whether an observed association is robust or potentially influenced by population-specific genetic backgrounds.
Interpreting Genetic Information
Genetic information regarding variants like rs17689918 is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions. Because the evidence linking this specific SNP to clinical outcomes is limited and often inconsistent, it cannot be used to predict an individual's risk for anxiety, depression, or their response to medication. If you are concerned about your mental health or have questions about how your genetics might influence your response to psychiatric treatments, it is essential to consult with a qualified clinician or pharmacist. They can provide personalized guidance based on your full medical history, current symptoms, and established clinical standards, rather than relying on isolated genetic data.
How common is this variant?
The minor allele frequency for rs17689918 is approximately 0.25–0.35 in European populations, making the variant relatively common.
Frequently asked questions
Can rs17689918 predict if I will develop depression?
No. Depression is a complex condition influenced by many genetic, environmental, and lifestyle factors. A single variant like rs17689918 does not have the predictive power to determine if an individual will develop a psychiatric disorder.
Should I change my medication based on this genotype?
Absolutely not. You should never alter your medication regimen based on genetic test results without consulting your doctor or pharmacist. Only a healthcare professional can evaluate whether genetic information is relevant to your specific treatment plan.
Is rs17689918 a 'bad' gene variant?
Genetic variants are not inherently 'good' or 'bad.' They are simply differences in DNA sequence. While some variants are associated with increased risk for certain traits, most, including rs17689918, are considered neutral variations that contribute to human genetic diversity.
Where can I find more information about CRHR1?
You can find reliable information about the CRHR1 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17689918?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRHR1
HPA-axis modulating variant in CRHR1 that interacts with psychosocial stress exposure to affect emotional reactivity and stress-coping traits.
Polymorphism within the CRHR1 locus tagged to haplotypes modulating cortisol release during the Trier Social Stress Test.
Key intronic polymorphism in the corticotropin-releasing hormone receptor 1 gene that moderates endocrine and emotional vulnerability after exposure to early life trauma.
Variant in the corticotropin-releasing hormone receptor 1 gene that moderates hypothalamic-pituitary-adrenal axis reactivity and vulnerability to stress-induced mood disturbances.
Intronic CRHR1 variant associated with neuroendocrine stress sensitivity.
Tag variant in the CRHR1 locus associated with HPA axis regulation.